Chronic kidney disease+1
Not recruitingA study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure
A study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure
- Disease:Chronic kidney diseaseHypertension
- Substances:BaxdrostatDapagliflozin
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Baxdrostat










